| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 10350 | 2013 |
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2314 | 2016 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1925* | 2020 |
| Subclonal diversification of primary breast cancer revealed by multiregion sequencing LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ... Nature medicine 21 (7), 751-759, 2015 | 863 | 2015 |
| Genomic evolution of breast cancer metastasis and relapse LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ... Cancer cell 32 (2), 169-184. e7, 2017 | 690 | 2017 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 457 | 2014 |
| Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track–letter A Torsvik, GV Røsland, A Svendsen, A Molven, H Immervoll, ... Cancer research 70 (15), 6393-6396, 2010 | 364 | 2010 |
| Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy S Welin, H Sorbye, S Sebjornsen, S Knappskog, C Busch, K Öberg Cancer 117 (20), 4617-4622, 2011 | 338 | 2011 |
| Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer S Nik-Zainal, DC Wedge, LB Alexandrov, M Petljak, AP Butler, N Bolli, ... Nature genetics 46 (5), 487-491, 2014 | 319 | 2014 |
| Gene expression profiling–based identification of molecular subtypes in stage IV melanomas with different clinical outcome G Jönsson, C Busch, S Knappskog, J Geisler, H Miletic, M Ringnér, ... Clinical cancer research 16 (13), 3356-3367, 2010 | 301 | 2010 |
| Somatic mutations reveal asymmetric cellular dynamics in the early human embryo YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ... Nature 543 (7647), 714-718, 2017 | 299 | 2017 |
| Australian Pancreatic Cancer Genome I LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ... Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013 | 219 | 2013 |
| Olaparib monotherapy as primary treatment in unselected triple negative breast cancer HP Eikesdal, S Yndestad, A Elzawahry, A Llop-Guevara, B Gilje, ES Blix, ... Annals of oncology 32 (2), 240-249, 2021 | 153 | 2021 |
| The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide S Knappskog, H Ravneberg, C Gjerdrum, C Tröβe, B Stern, IF Pryme Journal of biotechnology 128 (4), 705-715, 2007 | 144 | 2007 |
| The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians S Knappskog, M Bjørnslett, LM Myklebust, PEA Huijts, MP Vreeswijk, ... Cancer cell 19 (2), 273-282, 2011 | 132 | 2011 |
| Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration M Smid, FG Rodríguez-González, AM Sieuwerts, R Salgado, ... Nature communications 7 (1), 12910, 2016 | 123 | 2016 |
| EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation E Eskilsson, GV Rosland, KM Talasila, S Knappskog, O Keunen, ... Neuro-oncology 18 (12), 1644-1655, 2016 | 120 | 2016 |
| CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary … R Chrisanthar, S Knappskog, E Løkkevik, G Anker, B Østenstad, ... PloS one 3 (8), e3062, 2008 | 106 | 2008 |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms A Venizelos, H Elvebakken, A Perren, O Nikolaienko, W Deng, IMB Lothe, ... Endocrine-related cancer 29 (1), 1-14, 2022 | 103 | 2022 |
| Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases IM Løes, H Immervoll, H Sorbye, JH Angelsen, A Horn, S Knappskog, ... International journal of cancer 139 (3), 647-656, 2016 | 102 | 2016 |
